Adult Sensory Processing Scale (ASPS) Version of Turkish (ASPS)

January 16, 2021 updated by: ZEYNEP BAHADIR AGCE, Uskudar University

Cross-cultural Adaptation, Reliability, and Validity of Turkish Adult Sensory Processing Scale (ASPS)

Purpose: Sensory processing is crucial to adaptive behavioral responses in occupational therapy. Nevertheless, information on sensory processing in adults is limited. The Adult Sensory Processing Scale (ASPS) measure behavioral responses indicative of sensory processing in different sensory systems. The aim of the study was to examine the cultural adaptation, reliability, and validity of the ASPS Turkish (ASPS-T).

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The current study comprises three parts: cross-cultural adaptation, piloting, and examination of psychometric properties of the ASPS-T. The researcher contacted the developers of the original ASPS and received written permission from the authors to translate it into Turkish. This study was conducted by the Helsinki Declaration and Uskudar University. Clinical Research Ethical Board approved the study. After receiving both written and oral information about the project, all the study participants provided a signed consent form.

Phase 1: The cross-cultural adaptation process Translating the Turkish version of ASPS and the cross-cultural adaptation procedure was carried out under the guidance of Beaton et al. Translation from English to Turkish was performed by two therapists whose mother tongue is Turkish, also have fluent in English. Each of the translations was reviewed by three therapists, after the consensus on the final version, it was turned down by two native English-speaking translators. The final version was compared with the original version to reveal any inconsistencies; no discrepancies were observed. During the translation phase, minimal adjust were made to address linguistic.

Phase 2: Piloting process A pre-assessment was made with a pilot study to explore ASPS-Turkish's cultural harmony. The translated questionnaire was completed by 20 participants to identify any items that were not coherent. Four participants stated that they could not understand the meaning of avoid-kaçınmak, so investigators suggested yaşamamak, and this was accepted by participants. Three participants could not respond to the first item on factor 10, because participants had not traveled by boat or rides before, so that, investigators added the phrase "all types of vehicles" was added to the sentence. All the authors meet to compare the ASPS-T with the original version and assess its suitability after the minimal change, concluding that the current correction did not cause any loss of the meaning of the word. After the changes, pilot study participants evaluated the intelligibility of the scale with a 1 to 5 Likert scale, and confirm the clearness unanimously of them. Therefore, the final version of the ASPS-T which has minor changes was the best representation of the original, and each item was found to be suitable for Turkish patients. The pilot study participants were not included in the sample. After cultural equivalence had been achieved, 405 healthy individuals aged 18 and over were asked to complete the ASPS questionnaire.

Phase 3: Analysis of psychometric properties Exploratory and Confirmatory Factor Analysis (EFA and CFA) were used to measure the construct validity of the instrument, and test-retest analysis (interclass correlation coefficient) and Cronbach's alpha were used to evaluate the reliability of the instrument.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
405

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • State
      • Istanbul, State, Turkey, 34662
        • Uskudar university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants consisted of university students, faculty employees, other employees, and their families. Each participant was invited to participate in the study through a face-to-face interview. After receiving both written and oral information about the project, all the participants who volunteered to take part provided a signed consent form. A total of 460 individuals were called to participate in the study and 55 individuals rejected. Fifty-five of the 405 participants were randomly selected to be re-interviewed, and participants completed the questionnaire again for test re-test protocol.

Description

Inclusion Criteria:

  • being aged 18-64 years, able to read and write, and being healthy

Exclusion Criteria:

  • Who has a diagnosis of any disorders that preventing from completing the survey such as cancer or cognitive problems.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Participants
The participants were invited to the study, then each participant was asked to complete the self-report questionnaires.
Other: no intervention
We didn't have an intervention program, we used two questionnaires to evaluate participants.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Adolescent/Adult Sensory Profile
Time Frame: 20 minutes
Adult Sensory Processing Scale is designed to measure different behavioral response patterns (over-responding, under-responding, and sensory seeking) of specific sensory systems (tactile, proprioceptive, vestibular, auditory, and visual) that are indicative of sensory processing challenges. Sensory responsiveness models related to different sensory systems in adults have been defined by over-responsiveness, under-responsiveness and sensory-seeking patterns similar to those in children. A total of 11 factors and 48 items are defined and the number of questions for each factor is different. All items are rated on a 5-point Likert scale with Never = 1, Rarely = 2, Sometimes = 3, Often = 4, and Always = 5.
20 minutes
Adolescent/Adult Sensory Profile
Time Frame: 18 minutes
The AASP was developed build on Dunn's sensory processing model and is suitable for aged over 11 years. It consists of 60 items and is used to evaluate individuals' sensory processing skills in daily life. Each item is related to responses to sensory input through six different sensory factors that refer to everyday activities, including taste/smell, movement, vision, touch, processing, auditory processing, and activity level. The responses of the participants' sensory stimuli are evaluated in four quadrants: low registration, sensory sensitivity, sensory avoiding, and sensory seeking. The responses record on a Likert scale as almost always, often, sometimes, rarely, and almost never, and the scores of the related items are added to supply the score for each quadrant. The tests to settle the validity and reliability of the AASP were completed by Ucgul et al.
18 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Uskudar University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Hacettepe University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: ORKUN ARAN, PHD, Hacettepe University
  • Study Chair: SEDEF ŞAHİN, PHD, Hacettepe University
  • Study Director: ZEYNEP BAHADIR AGCE, PHD, Uskudar university

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2019

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 1, 2020

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 1, 2020

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 9, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 13, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 19, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 22, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 16, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 61351342-193

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sensory Processing Disorder

Clinical Trials on no intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings